Which has the lower trailing P/E, BMY or PFE?

BMY has the lower trailing P/E: BMY trades at 14.02 and PFE at 36.63. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BMY or PFE?

Over the past five years, PFE grew revenue faster — BMY at a 2.08% CAGR versus PFE at 6.29%.

Does BMY or PFE pay a bigger dividend?

BMY yields 3.94% and PFE yields 6.19% based on trailing dividends and the latest price.

Is BMY or PFE more profitable?

BMY runs the higher net margin — BMY at 18.87% versus PFE at 6.81%.

How have BMY and PFE total returns compared?

Over the past 10 years, BMY delivered 5.01% and PFE delivered 3.17% annualized total return. Past performance doesn't predict future results.

Bristol-Myers Squibb Company (BMY) vs Pfizer Inc. (PFE)

A side-by-side comparison of Bristol-Myers Squibb Company and Pfizer Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.

BMY

Bristol-Myers Squibb Company

$130.00B

$63.64HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

PFE

Pfizer Inc.

$157.99B

$27.72HealthcareDelayed quote: Sep 11, 2026, 4:01 PM EDT

Total return — BMY vs PFE

growth of $100 · dividends reinvested · last 10y

BMY +68.1% (+5.3%/yr)PFE +37.3% (+3.2%/yr)BMY compounded faster over this window

BMY PFE

BMY vs PFE: by the numbers

•PFE is the larger company ($157.99B vs $130.00B market cap).
•BMY trades at the lower trailing earnings multiple (14.02 vs 36.63 P/E), one valuation lens rather than an overall verdict.
•BMY converts more revenue to profit (18.87% vs 6.81% net margin).
•PFE grew revenue faster over the past five years (6.29% vs 2.08% CAGR).
•PFE pays the higher dividend yield (6.19% vs 3.94%).

Metrics side by side

Valuation

Metric	BMY	PFE
P/E ratio	14.02	36.63
Forward P/E	9.18	9.32
P/S ratio	2.64	2.48
P/B ratio	5.82	1.85
EV / EBITDA	9.71	10.15
FCF yield	8.80%	6.95%

Profitability

Metric	BMY	PFE
Gross margin	70.16%	71.32%
Operating margin	28.27%	25.08%
Net margin	18.87%	6.81%
ROE	41.59%	5.09%
ROIC	15.47%	9.33%

Dividends

Metric	BMY	PFE
Dividend yield	3.94%	6.19%
Payout ratio	55.29%	227.27%

Growth (annualized)

Metric	BMY	PFE
Revenue CAGR (5Y)	2.08%	6.29%
EPS CAGR (5Y)	9.38%	-3.78%
FCF CAGR (5Y)	-0.95%	-3.11%
Total return CAGR (5Y)	4.39%	-4.68%

Frequently asked

Which has the lower trailing P/E, BMY or PFE?: BMY has the lower trailing P/E: BMY trades at 14.02 and PFE at 36.63. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BMY or PFE?: Over the past five years, PFE grew revenue faster — BMY at a 2.08% CAGR versus PFE at 6.29%.
Does BMY or PFE pay a bigger dividend?: BMY yields 3.94% and PFE yields 6.19% based on trailing dividends and the latest price.
Is BMY or PFE more profitable?: BMY runs the higher net margin — BMY at 18.87% versus PFE at 6.81%.
How have BMY and PFE total returns compared?: Over the past 10 years, BMY delivered 5.01% and PFE delivered 3.17% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BMY analysis Full PFE analysis Interactive comparison tool

Dig into the metrics

Bristol-Myers Squibb P/E ratio Pfizer P/E ratio Bristol-Myers Squibb dividend yield Pfizer dividend yield Bristol-Myers Squibb ROE Pfizer ROE Bristol-Myers Squibb operating margin Pfizer operating margin Bristol-Myers Squibb revenue growth Pfizer revenue growth Bristol-Myers Squibb free cash flow Pfizer free cash flow

Bristol-Myers Squibb & Pfizer appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.